RT Journal Article
SR Electronic
T1 Can herd immunity be achieved without breaking ICUs?
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.26.20113746
DO 10.1101/2020.05.26.20113746
A1 De Brouwer, Edward
A1 Raimondi, Daniele
A1 Moreau, Yves
YR 2020
UL http://medrxiv.org/content/early/2020/05/27/2020.05.26.20113746.abstract
AB The current COVID-19 pandemic led to the rapid overload of Intensive Care Units (ICUs) in countries where the outbreaks was not quickly controlled.The containment measures put in place to control the outbreaks had a huge social and economic impacts, and countries are looking for strategies to relax these measures while maintaining the R0 close or below 1, in an attempt to safely reach herd immunity.In this paper we analyse the feasibility of reaching herd immunity without saturating ICUs across countries. We provide an online tool, available at www.about-the-curve.net that simulates the time required for such a scenario with a SIR model. For United States, we find that a minimum of 5 months would be required, 22 months for UK, 1 year for Italy and 9 months for Belgium.Disclaimer The presented results are preliminary and have not been peer-reviewed.Competing Interest StatementThe authors have declared no competing interest.Funding StatementYM is funded by Research Council KU Leuven: C14/18/092 SymBioSys3 CELSA-HIDUCTION CELSA/17/032 Flemish Government:IWT: Exaptation PhD grantsFWO 06260 (Iterative and multi-level methods for Bayesian multirelational factor-ization with features) This research received funding from the Flemish Governmentunder the Onderzoeksprogramma Artificiele Intelligentie (AI) Vlaanderen pro-gramme. EU: MELLODDY This project has received funding from the InnovativeMedicines Initiative 2 Joint Undertaking under grant agreement No 831472. ThisJoint Undertaking receives support from the European Unions Horizon 2020 researchand innovation programme and EFPIA. DR is funded by a FWO postdoctoral fellowship and EDB is funded by a FWO-SB grant.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No IRB or ethics committee required.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data was collected from :https://coronavirus.jhu.edu/map.html https://coronavirus.jhu.edu/map.html